Results 21 to 30 of about 530,449 (156)

Endovascular management of a pulmonary artery pseudoaneurysm secondary to mucormycosis: A case report

Radiology Case Reports, 2023
The development of pulmonary artery pseudoaneurysm (PAP) secondary to pulmonary mucormycosis (PM) is exceedingly rare. Without immediate intervention, PAPs can result in life-threatening hemorrhage as these weakening vessels are prone to rupture.
Kelly Trinh, Duc Le, Thomas Callahan
doaj   +3 more sources

A case of concomitant pulmonary tuberculosis and mucormycosis in an insulin-dependent diabetic patient [PDF]

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2019
Conditions, where the patient's immune system is compromised are the main risk factor for mucormycosis. Approximately 23% of the world's population is estimated to have a latent Mycobacterium tuberculosis infection and more than 10 million new cases were
Jiménez-Zarazúa O, Vélez-Ramírez LN, Alcocer-León M, Utrilla-Álvarez JD, Martínez-Rivera MA, Flores-Saldaña GA, Mondragón JD   +6 more
doaj   +3 more sources

Pulmonary Mucormycosis in a Patient with Systemic Lupus Erythematosus: A Diagnostic and Treatment Challenge

Case Reports in Infectious Diseases, 2015
Pulmonary mucormycosis is commonly encountered in patients with diabetic ketoacidosis, hematologic malignancies, neutropenia, organ or hematopoietic stem cell transplantation, and malignancy, but it rarely occurs in high-risk patients with systemic lupus
Hung-Chang Hung, Gang-Yu Shen, Shiuan-Chih Chen, Kai-Jieh Yeo, Shih-Ming Tsao, Meng-Chih Lee, Yuan-Ti Lee   +6 more
doaj   +2 more sources

Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study

Current Medical Issues
Background: Pulmonary mucormycosis is a rare life-threatening fungal infection that primarily affects immunocompromised individuals, leading to severe morbidity and high mortality.
Ashwin Oliver Arul, K. Rajiv Karthik, Devasahayam Jesudas Christopher   +2 more
doaj   +2 more sources

Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis. [PDF]

PLoS ONE
BackgroundPulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes.
Junjun Wan, Teng Liu, Fang Li, Shaohua Xu   +3 more
doaj   +2 more sources

Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]

Current Medical Mycology, 2023
Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman, Jayaraj Athimanjeri Thiruvengadam, Abinaya Ravichandran, Santhi Thoppappatty Sengottaiyan   +3 more
doaj   +1 more source

Clinical characteristics, outcome, and factors associated with mortality of pulmonary mucormycosis: a retrospective single-center study from Pakistan

Therapeutic Advances in Infectious Disease
Introduction and objective: Pulmonary mucormycosis is a rare but rapidly progressive fatal disease. Limited data exist on the outcomes and factors associated with poor prognosis of pulmonary mucormycosis.
Rameesha Khalid, Iffat Khanum, Kiren Habib, Akbar Shoukat Ali, Joveria Farooqi, Nousheen Iqbal, Taymmia Ejaz, Kauser Jabeen, Muhammad Irfan   +8 more
doaj   +2 more sources

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole

European Journal of Medical Research, 2021
Background Mucormycosis is a rare fungal infection occurring chiefly in the lung or the rhino-orbital-cerebral compartment, particularly in patients with immunodeficiency or diabetes mellitus. Among Mucorales fungi, Rhizopus spp.
F. Yuan, J. Chen, F. Liu, Y. C. Dang, Q. T. Kong, H. Sang   +5 more
doaj   +1 more source

Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature

BMC Pulmonary Medicine, 2021
Background Pulmonary mucormycosis caused by Mucorales is a highly lethal invasive fungal infection usually found in immunocompromised patients. Isolated pulmonary mucormycosis in immunocompetent patients is very rare. Here, we present a case of a 32-year-
Jianhan He, Gaohong Sheng, Huihui Yue, Fengqin Zhang, Hui-Lan Zhang   +4 more
doaj   +1 more source

Clinical Manifestation, mNGS Based Diagnosis and Treatment of Pulmonary Mucormycosis with Rhizopus delemar in a Diabetic Patient

Infection and Drug Resistance
Xuesong Cheng,1 Tianyu Li,2 Fengsheng Wu,2 Dandan Liu1 1The Department of Pulmonary and Critical Care Medicine, Anhui No.2 Provincial People’s Hospital, Hefei, People’s Republic of China; 2Genoxor Medical Science and Technology Inc., Shanghai, People’s ...
Cheng X, Li T, Wu F, Liu D
doaj   +2 more sources